{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:10Z","timestamp":1792788190127,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":117,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Basic and Applied Basic Research Foundation of Department of Science and Technology of Guangdong Province","award":["2022A1515111208"],"award-info":[{"award-number":["2022A1515111208"]}],"id":[{"id":"https:\/\/ror.org\/00tjzgn92","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Science and Technology Projects of Guangzhou Municipal Science and Technology Bureau","award":["2024A04J3533"],"award-info":[{"award-number":["2024A04J3533"]}],"id":[{"id":"https:\/\/ror.org\/0560dtp08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-026-00863-6","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:05:14Z","timestamp":1781327114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of intravenous combined with aerosolized colistimethate sodium for carbapenem-resistant organism-induced pneumonia: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Ji","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"7","key":"863_CR1","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1093\/cid\/ciaa122","volume":"71","author":"DM Livermore","year":"2020","unstructured":"Livermore DM, Nicolau DP, Hopkins KL, Meunier D. Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its Sell-By Date in an Era of New Antibiotics and Regional Carbapenemase Epidemiology. Clin Infect Dis. 2020;71(7):1776\u201382.","journal-title":"Clin Infect Dis"},{"key":"863_CR2","doi-asserted-by":"publisher","first-page":"772372","DOI":"10.3389\/fmed.2022.772372","volume":"9","author":"K Chang","year":"2022","unstructured":"Chang K, Wang H, Zhao J, Yang X, Wu B, Sun W, Huang M, Cheng Z, Chen H, Song Y, et al. Polymyxin B\/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii. Front Med (Lausanne). 2022;9:772372.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"863_CR3","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3201\/eid2007.121004","volume":"20","author":"ME Falagas","year":"2014","unstructured":"Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170\u20135.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"863_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","volume":"8","author":"D van Duin","year":"2017","unstructured":"van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460\u20139.","journal-title":"Virulence"},{"issue":"2","key":"863_CR5","doi-asserted-by":"publisher","first-page":"ofv050","DOI":"10.1093\/ofid\/ofv050","volume":"2","author":"HJ Morrill","year":"2015","unstructured":"Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. Open Forum Infect Dis. 2015;2(2):ofv050.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"863_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jac\/dkw377","volume":"72","author":"O Zusman","year":"2017","unstructured":"Zusman O, Altunin S, Koppel F, Dishon Benattar Y, Gedik H, Paul M. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis. J Antimicrob Chemother. 2017;72(1):29\u201339.","journal-title":"J Antimicrob Chemother"},{"issue":"suppl2","key":"863_CR7","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1093\/cid\/ciy692","volume":"67","author":"J Xie","year":"2018","unstructured":"Xie J, Yang Y, Huang Y, Kang Y, Xu Y, Ma X, Wang X, Liu J, Wu D, Tang Y, et al. The Current Epidemiological Landscape of Ventilator-associated Pneumonia in the Intensive Care Unit: A Multicenter Prospective Observational Study in China. Clin Infect Dis. 2018;67(suppl2):S153\u201361.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"863_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3855\/jidc.12012","volume":"14","author":"AM Farag","year":"2020","unstructured":"Farag AM, Tawfick MM, Abozeed MY, Shaban EA, Abo-Shadi MA. Microbiological profile of ventilator-associated pneumonia among intensive care unit patients in tertiary Egyptian hospitals. J Infect Dev Ctries. 2020;14(2):153\u201361.","journal-title":"J Infect Dev Ctries"},{"issue":"41","key":"863_CR9","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.3346\/jkms.2021.36.e251","volume":"36","author":"Y Chang","year":"2021","unstructured":"Chang Y, Jeon K, Lee SM, Cho YJ, Kim YS, Chong YP, Hong SB. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia\/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study. J Korean Med Sci. 2021;36(41):e251.","journal-title":"J Korean Med Sci"},{"key":"863_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/1471-2334-13-561","volume":"13","author":"AA Quartin","year":"2013","unstructured":"Quartin AA, Scerpella EG, Puttagunta S, Kett DH. A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis. 2013;13:561.","journal-title":"BMC Infect Dis"},{"key":"863_CR11","unstructured":"WHO bacterial priority pathogens list. 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance: World Health Organization; 2024."},{"issue":"2","key":"863_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","volume":"75","author":"D van Duin","year":"2013","unstructured":"van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis. 2013;75(2):115\u201320.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"863_CR13","doi-asserted-by":"publisher","first-page":"ofx176","DOI":"10.1093\/ofid\/ofx176","volume":"4","author":"B Cai","year":"2017","unstructured":"Cai B, Echols R, Magee G, Arjona Ferreira JC, Morgan G, Ariyasu M, Sawada T, Nagata TD. Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect Dis. 2017;4(3):ofx176.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"863_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/idr13020038","volume":"13","author":"H Ben Lakhal","year":"2021","unstructured":"Ben Lakhal H, M\u2019Rad A, Naas T, Brahmi N. Antimicrobial Susceptibility among Pathogens Isolated in Early- versus Late-Onset Ventilator-Associated Pneumonia. Infect Dis Rep. 2021;13(2):401\u201310.","journal-title":"Infect Dis Rep"},{"issue":"6","key":"863_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ijantimicag.2014.07.004","volume":"44","author":"WJ Gu","year":"2014","unstructured":"Gu WJ, Wang F, Tang L, Bakker J, Liu JC. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis. Int J Antimicrob Agents. 2014;44(6):477\u201385.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"863_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-022-03947-9","volume":"26","author":"SH Wang","year":"2022","unstructured":"Wang SH, Yang KY, Sheu CC, Chen WC, Chan MC, Feng JY, Chen CM, Wu BR, Zheng ZR, Chou YC, Peng CK. The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study. Crit Care. 2022;26(1):91.","journal-title":"Crit Care"},{"key":"863_CR17","doi-asserted-by":"publisher","first-page":"175346661988552","DOI":"10.1177\/1753466619885529","volume":"13","author":"J Choe","year":"2019","unstructured":"Choe J, Sohn YM, Jeong SH, Park HJ, Na SJ, Huh K, Suh GY, Jeon K. Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria. Ther Adv Respir Dis. 2019;13:1753466619885529.","journal-title":"Ther Adv Respir Dis"},{"issue":"6","key":"863_CR18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1378\/chest.10-0463","volume":"138","author":"R Imberti","year":"2010","unstructured":"Imberti R, Cusato M, Villani P, Carnevale L, Iotti GA, Langer M, Regazzi M. Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. Chest. 2010;138(6):1333\u20139.","journal-title":"Chest"},{"issue":"12","key":"863_CR19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","volume":"30","author":"LM Lim","year":"2010","unstructured":"Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A 3rd, Forrest A, Bulitta JB, Tsuji BT. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy. 2010;30(12):1279\u201391.","journal-title":"Pharmacotherapy"},{"issue":"10","key":"863_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.cmi.2019.04.018","volume":"25","author":"DA Sweeney","year":"2019","unstructured":"Sweeney DA, Kalil AC. Why don\u2019t we have more inhaled antibiotics to treat ventilator-associated pneumonia? Clin Microbiol Infect. 2019;25(10):1195\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"863_CR21","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1177\/1060028017723934","volume":"51","author":"GC Wood","year":"2017","unstructured":"Wood GC, Swanson JM. An Update on Aerosolized Antibiotics for Treating Hospital-Acquired and Ventilator-Associated Pneumonia in Adults. Ann Pharmacother. 2017;51(12):1112\u201321.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"863_CR22","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O\u2019Grady NP, Bartlett JG, Carratal\u00e0 J, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61\u2013111.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"863_CR23","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1097\/CCM.0000000000001539","volume":"44","author":"P Korkmaz Ekren","year":"2016","unstructured":"Korkmaz Ekren P, Toreyin N, Sayiner A, Bacakoglu F. The Role of Aerolized Colistin in the Treatment of Hospital-Acquired Pneumonia: Experience of Multicenter From Turkey. Crit Care Med. 2016;44(5):e304.","journal-title":"Crit Care Med"},{"issue":"3","key":"863_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/CCM.0000000000000771","volume":"43","author":"A Valachis","year":"2015","unstructured":"Valachis A, Samonis G, Kofteridis DP. The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis. Crit Care Med. 2015;43(3):527\u201333.","journal-title":"Crit Care Med"},{"issue":"55","key":"863_CR25","first-page":"466","volume":"24","author":"SMZM Xie","year":"2008","unstructured":"Xie SMZM, Yang JB, Li YJ, Zhao DH. Considerations and determination on the evaluation criterion for clinical efficacy of antibacterial agents in China. Chin J Clin Pharmacol. 2008;24(55):466\u20138.","journal-title":"Chin J Clin Pharmacol"},{"key":"863_CR26","unstructured":"Zhang X. Dermatovenereology (eighth edition). People\u2019s Medical Publishing House; 2013."},{"issue":"17","key":"863_CR27","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","volume":"368","author":"G Yosipovitch","year":"2013","unstructured":"Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368(17):1625\u201334.","journal-title":"N Engl J Med"},{"key":"863_CR28","unstructured":"Jia J, Chen S. Neurology. 8th ed. Beijing: People's Medical Publishing House; 2018."},{"key":"863_CR29","unstructured":"Lin GWWJ, Ge JB. Practice of internal medicine. People\u2019s Medical Publishing House; 2017."},{"issue":"4","key":"863_CR30","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract. 2012;120(4):c179\u201384.","journal-title":"Nephron Clin Pract"},{"issue":"9","key":"863_CR31","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1164\/rccm.201303-0437ST","volume":"187","author":"JP Parsons","year":"2013","unstructured":"Parsons JP, Hallstrand TS, Mastronarde JG, Kaminsky DA, Rundell KW, Hull JH, Storms WW, Weiler JM, Cheek FM, Wilson KC, Anderson SD. An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 2013;187(9):1016\u201327.","journal-title":"Am J Respir Crit Care Med"},{"key":"863_CR32","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, Xie L, Yang C, Ma X, Li H, et al. Epidemiology of carbapenem-resistant enterobacteriaceae infections: report from the China CRE network. Antimicrob Agents Chemother. 2018;62(2):e01882-17.","DOI":"10.1128\/AAC.01882-17"},{"issue":"1","key":"863_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13756-020-00872-w","volume":"10","author":"X Zhen","year":"2021","unstructured":"Zhen X, St\u00e5lsby Lundborg C, Sun X, Zhu N, Gu S, Dong H. Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrob Resist Infect Control. 2021;10(1):5.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"8","key":"863_CR34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10096-008-0494-6","volume":"27","author":"YH Xiao","year":"2008","unstructured":"Xiao YH, Wang J, Li Y, Net MOHNARI. Bacterial resistance surveillance in China: a report from Mohnarin 2004\u20132005. Eur J Clin Microbiol Infect Dis. 2008;27(8):697\u2013708.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"863_CR35","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","volume":"22","author":"FP Hu","year":"2016","unstructured":"Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, Zhang CX, Ji P, Xie Y, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014. Clin Microbiol Infect. 2016;22(Suppl 1):S9\u201314.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"863_CR36","doi-asserted-by":"publisher","first-page":"7331","DOI":"10.1128\/AAC.03510-14","volume":"58","author":"M Boisson","year":"2014","unstructured":"Boisson M, Jacobs M, Gregoire N, Gobin P, Marchand S, Couet W, Mimoz O. Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients. Antimicrob Agents Chemother. 2014;58(12):7331\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"863_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmi.2017.04.011","volume":"23 9","author":"J Rello","year":"2017","unstructured":"Rello J, Sol\u00e9-Lleonart C, Rouby JJ, Chastre J, Blot SI, Poulakou G, Luyt C-E, Riera J, Palmer LB, Pereira JM, et al. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect. 2017;23 9:629\u201339.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"863_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"BT Tsuji","year":"2019","unstructured":"Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A, Giacobbe DR, Viscoli C, Giamarellou H, Karaiskos I, et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019;39(1):10\u201339.","journal-title":"Pharmacotherapy"},{"issue":"11","key":"863_CR39","first-page":"e49314","volume":"15","author":"L Maan","year":"2023","unstructured":"Maan L, Anand N, Yadav G, Mishra M, Gupta MK. The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection. Cureus. 2023;15(11):e49314.","journal-title":"Cureus"},{"key":"863_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ijid.2021.06.007","volume":"108","author":"TA Almangour","year":"2021","unstructured":"Almangour TA, Alruwaili A, Almutairi R, Alrasheed A, Alhifany AA, Eljaaly K, Alkofide H, Alhammad AM, Ghonem L, Alsharidi A. Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study. Int J Infect Dis. 2021;108:406\u201312.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"863_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.21037\/jtd.2017.02.61","volume":"9","author":"YK Kim","year":"2017","unstructured":"Kim YK, Lee JH, Lee HK, Chung BC, Yu SJ, Lee HY, Park JH, Kim S, Kim HK, Kiem S, Jang HJ. Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. J Thorac Dis. 2017;9(3):555\u201367.","journal-title":"J Thorac Dis"},{"issue":"5","key":"863_CR42","doi-asserted-by":"publisher","first-page":"e15774","DOI":"10.1016\/j.heliyon.2023.e15774","volume":"9","author":"D Lu","year":"2023","unstructured":"Lu D, Mao W. Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis. Heliyon. 2023;9(5):e15774.","journal-title":"Heliyon"},{"issue":"1","key":"863_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/cc3036","volume":"9","author":"S Mubareka","year":"2005","unstructured":"Mubareka S, Rubinstein E. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care. 2005;9(1):29\u201330.","journal-title":"Crit Care"},{"issue":"3","key":"863_CR44","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.rmed.2007.10.011","volume":"102","author":"A Michalopoulos","year":"2008","unstructured":"Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med. 2008;102(3):407\u201312.","journal-title":"Respir Med"},{"issue":"4","key":"863_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1684-1182(10)60050-3","volume":"43","author":"CC Lin","year":"2010","unstructured":"Lin CC, Liu TC, Kuo CF, Liu CP, Lee CM. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan. J Microbiol Immunol Infect. 2010;43(4):323\u201331.","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"863_CR46","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.21037\/apm-22-984","volume":"11","author":"XL Bao","year":"2022","unstructured":"Bao XL, Tao T, Tang N, Wang YZ, Liao XQ, Huang LL, Ji JJ, Chen X. Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study. Ann Palliat Med. 2022;11(9):2939\u201351.","journal-title":"Ann Palliat Med"},{"issue":"9","key":"863_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmi.2017.04.011","volume":"23","author":"J Rello","year":"2017","unstructured":"Rello J, Sol\u00e9-Lleonart C, Rouby JJ, Chastre J, Blot S, Poulakou G, Luyt CE, Riera J, Palmer LB, Pereira JM, et al. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect. 2017;23(9):629\u201339.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"863_CR48","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s10156-012-0430-7","volume":"18","author":"G Kalin","year":"2012","unstructured":"Kalin G, Alp E, Coskun R, Demiraslan H, G\u00fcndogan K, Doganay M. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment? J Infect Chemother. 2012;18(6):872\u20137.","journal-title":"J Infect Chemother"},{"issue":"9","key":"863_CR49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2217\/cer-2020-0013","volume":"9","author":"V Allan","year":"2020","unstructured":"Allan V, Ramagopalan SV, Mardekian J, Jenkins A, Li X, Pan X, Luo X. Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants. J Comp Eff Res. 2020;9(9):603\u201314.","journal-title":"J Comp Eff Res"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-026-00863-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-026-00863-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-026-00863-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:39:36Z","timestamp":1791416376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12941-026-00863-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["863"],"URL":"https:\/\/doi.org\/10.1186\/s12941-026-00863-6","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the chief ethics committee (Zhujiang Hospital of Southern Medical University; Ethics No. 2024-KY-056-01) of all participating hospitals. The study was in accordance with the conditions for mutual recognition of ethics approval, and the participating hospitals recognized the ethics approval of the ethics committee of Zhujiang Hospital of Southern Medical University. The study was conducted in accordance with the Helsinki Declaration of 1964, study data were fully deidentified, and confidential information was deleted from patients in accordance with the World Health Organization International Ethical Guidelines for Health-related Research Involving Humans (2016), and requirement for informed consent was waived by the ethics committee of Zhujiang Hospital of Southern Medical University.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"40"}}